Patents Assigned to Genesys Pharma Inc.
  • Antisense oligonucleotides targeted against human immunodeficiency virus
    Patent number: 5594122
    Abstract: The present invention is directed to oligonucleotides comprising nucleotide sequences sufficiently complementary to conserved regions of human immunodeficiency virus genetic material such that when bound to said region, the oligonucleotides effectively prevent expression of the genetic material.
    Type: Grant
    Filed: September 19, 1994
    Date of Patent: January 14, 1997
    Assignee: Genesys Pharma Inc.
    Inventor: Albert D. Friesen